Eisai Pricing For Lecanemab Reflects Concern With Medicare ‘Sustainability,’ ‘Giving Back,’ Firm Says

Lecanemab and Medicare
A Public Spirited Approach To Drug Pricing? • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Market Access

More from Pink Sheet